Jove
Visualize
Contact Us

Related Experiment Videos

[Orphan diseases]

A Loizzo1, M T Tebano

  • 1Laboratorio di Farmacologia, Istituto Superiore di Sanità, Roma.

Recenti Progressi in Medicina
|November 1, 1993
PubMed
Summary

This study proposes a shift from orphan drug research to a disease-centric approach for rare diseases. By classifying and studying rare diseases, we can better understand their pathophysiology and develop effective treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postnatal Stress in Mice: Effects on Body Fat, Plasma Lipids, Glucose and Insulin.

Nutritional neuroscience·2016
Same author

Pain and child: a translational hypothesis on the pathophysiology of a mild type-2 diabetes model.

Endocrine, metabolic & immune disorders drug targets·2011
Same author

Formation of an adduct by clenbuterol, a beta-adrenoceptor agonist drug, and serum albumin in human saliva at the acidic pH of the stomach: evidence for an aryl radical-based process.

Free radical biology & medicine·2008
Same author

Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease.

Purinergic signalling·2008
Same author

Is the functional interaction between adenosine A(2A) receptors and metabotropic glutamate 5 receptors a general mechanism in the brain? Differences and similarities between the striatum and the hippocampus.

Purinergic signalling·2008
Same author

Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus.

Journal of neurochemistry·2007
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Focuses on rare disease research, bridging basic science and clinical application.

Context:

  • Industrial research predominantly addresses common diseases, neglecting rare 'orphan diseases'.
  • This imbalance limits understanding of rare disease pathophysiology and treatment options.

Purpose:

  • To stimulate innovative basic research into orphan diseases.
  • To shift focus from orphan drugs to a comprehensive study of rare diseases themselves.
  • To establish a framework for classifying and estimating rare diseases.

Summary:

  • Proposes a disease-first strategy over a drug-first strategy for orphan diseases.
  • Advocates for a national research plan to fund rare disease pathophysiology and therapy studies.
  • Suggests that understanding disease prevalence, clinical features, and prognosis is key.

Impact:

  • Aims to reduce the number of incurable rare diseases.
  • Could lead to a coordinated European Community approach to rare disease research.
  • Facilitates targeted allocation of financial resources for orphan disease studies.

Related Experiment Videos